Judge hands win to FDA, Lilly in tirzepatide shortage casenews2025-05-07T16:37:46+00:00May 7th, 2025|Endpoints News|
States sue US over plan for reorganization of federal health agenciesnews2025-05-06T19:29:20+00:00May 6th, 2025|Endpoints News|
SEC expected to drop investigation of Illumina’s $8B Grail dealnews2025-05-06T18:56:03+00:00May 6th, 2025|Endpoints News|
BeiGene gets key win in patent spat over Brukinsanews2025-04-30T19:42:52+00:00April 30th, 2025|Endpoints News|
Regeneron loses bid to fend off false claims fight over Eyleanews2025-04-30T17:41:33+00:00April 30th, 2025|Endpoints News|
AstraZeneca posts another Truqap study fail, says China import tax could triplenews2025-04-29T10:37:06+00:00April 29th, 2025|Endpoints News|
Bill cutting tax deductions for drug ads could help fund ‘pill penalty’ fixnews2025-04-28T18:27:40+00:00April 28th, 2025|Endpoints News|
Compounding pharmacies dealt blow in semaglutide shortage casenews2025-04-25T17:59:29+00:00April 25th, 2025|Endpoints News|
Halozyme launches patent fight over Merck’s injectable Keytrudanews2025-04-24T16:58:38+00:00April 24th, 2025|Endpoints News|
Top pharma companies increased lobbying spend at start of 2025news2025-04-23T18:38:26+00:00April 23rd, 2025|Endpoints News|
